GlobeNewswire

THE PROGENICS BOARD HAS THE EXPERIENCE NECESSARY TO SUCCESSFULLY OVERSEE THE CONTINUED COMMERCIALIZATION OF AZEDRA AND THE COMPANY’S PIPELINE OF OTHER RADIOPHARMACEUTICALS

THE PROGENICS BOARD HAS THE EXPERIENCE NECESSARY TO SUCCESSFULLY OVERSEE THE CONTINUED COMMERCIALIZATION OF AZEDRA AND THE COMPANY’S PIPELINE OF OTHER RADIOPHARMACEUTICALS

We strongly believe the Progenics Board has the right mix of skills and experience to effectively guide the Company to long-term success.
Progenics Pharmaceuticals Inc.
Format

PNG

Source

Progenics Pharmaceuticals Inc.

Downloads

Progenics to Mail Letter to Shareholders